Bicycle Therapeutics (BCYC) Non-cash Items (2018 - 2026)
Bicycle Therapeutics (BCYC) reported Non-cash Items of $7.3 million for Q1 2026, up 20.47% on a YoY basis from $6.0 million in Q1 2025, and up 170.72% quarter-over-quarter from $2.7 million in Q4 2025.
Bicycle Therapeutics (BCYC) Non-cash Items (2018 - 2026) Analysis & Trends
Bicycle Therapeutics has reported Non-cash Items for 9 years, with the latest figure at $7.3 million in Q1 2026.
- For the quarter ending Q1 2026, Non-cash Items rose 20.47% year-over-year to $7.3 million; the trailing twelve-month figure through Mar 2026 stood at $7.3 million (up 20.47% YoY), and the FY2025 full-year result was $2.7 million, down 71.96% from the prior year.
- Non-cash Items for Q1 2026 stood at $7.3 million, up from $2.7 million in the prior quarter.
- The five-year high for Non-cash Items was $71.0 million in Q4 2022, with the low at $2.7 million in Q2 2025.
- Historically, Non-cash Items has averaged $18.1 million across 5 years, with a median of $6.0 million in 2025.
- The largest YoY upside for Non-cash Items was 1900.1% in 2022 against a maximum downside of 96.57% in 2022.
- Bicycle Therapeutics' Non-cash Items stood at $71.0 million in 2022, then slumped by 69.13% to $21.9 million in 2023, then plunged by 56.39% to $9.6 million in 2024, then slumped by 71.96% to $2.7 million in 2025, then soared by 170.72% to $7.3 million in 2026.
- The last three Non-cash Items figures came in at $7.3 million (Q1 2026), $2.7 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.26 Mn |
| Mar 31, 2026 | 7.26 Mn |
| Dec 31, 2025 | 2.68 Mn |
| Dec 31, 2025 | 2.68 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | 6.02 Mn |
| Mar 31, 2025 | 6.02 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Sep 30, 2024 | 5.09 Mn |
| Sep 30, 2024 | 5.09 Mn |
| Jun 30, 2024 | 30.75 Mn |
| Jun 30, 2024 | 30.75 Mn |
| Mar 31, 2024 | 4.96 Mn |
| Mar 31, 2024 | 4.96 Mn |
| Dec 31, 2023 | 21.92 Mn |
| Dec 31, 2023 | 21.92 Mn |